Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Su, C. Y.
  • Wang, S. Y.
  • Shie, J. J.
  • Jeng, K. S.
  • Temperton, N. J.
  • Fang, J. M.
  • Wong, Chi-Huey
  • Cheng, Y. S. E.

publication date

  • September 2008

journal

  • Antiviral Research  Journal

abstract

  • For the treatment of influenza virus infections, neuraminidase inhibitors (NAIs) that prevent the release of virus particles have been effective against most influenza strains. Several neuraminidase (NA) assays are available for the evaluation of NAIs. To understand the NAI functions under physiological conditions, assays mimicking viral particle release should be useful. We have constructed retrovirus-based reporter viruses that are pseudotyped with hemagglutinin (HA) glycoprotein by transfection of producer cells using plasmids expressing retroviral gag-pol, influenza HA, NA, and firefly luciferase genes. Similarly to the life cycle of influenza viruses, the release of pseudotype viruses also requires neuraminidase functions. This requirement was used to develop an assay to evaluate NAI activities by measuring inhibition of pseudotype virus production at different NAI concentrations. The pseudotype virus release assay was used to determine the IC(50) values of Oseltamivir carboxylate, Zanamivir, and the novel phosphonate congeners of Oseltamivir against N1 group neuraminidases and their H274Y Oseltamivir carboxylate-resistant mutants. The deduced IC(50) values obtained using the release assay correlated with those determined using the fluorogenic substrate 2'-(4-methylumbelliferyl)-alpha-d-N-acetylneuraminic acid (MUNANA) and also correlated with the infectivity results.

subject areas

  • Animals
  • Antiviral Agents
  • Cell Line
  • Chick Embryo
  • Drug Evaluation, Preclinical
  • Enzyme Inhibitors
  • Genes, Reporter
  • Genetic Engineering
  • Hemagglutinins, Viral
  • Humans
  • Influenza, Human
  • Leukemia Virus, Murine
  • Neuraminidase
  • Orthomyxoviridae
  • Oseltamivir
  • Virus Shedding
  • Zanamivir
scroll to property group menus

Research

keywords

  • antiviral
  • drug resistance
  • neuraminidase inhibitor
  • pseudotype virus
  • viral release assay
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0166-3542

Digital Object Identifier (DOI)

  • 10.1016/j.antiviral.2008.03.002

PubMed ID

  • 18453004
scroll to property group menus

Additional Document Info

start page

  • 199

end page

  • 205

volume

  • 79

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support